Advertisement

Organisation › Details
Integrated Diagnostics Inc. (Indi)
Integrated Diagnostics is developing large-scale, blood-based molecular diagnostics that detect important diseases like lung cancer and Alzheimer's at their earliest stages by simultaneously monitoring tens to hundreds of disease markers. The company, founded in October 2009 by systems biology pioneer Dr. Lee Hood, is creating a new generation of personalized medical solutions using sophisticated informatics for biomarker selection and a novel class of synthetically created diagnostic and therapeutic agents with antibody-like properties: protein-catalyzed capture agents. Integrated Diagnostics' mission is to build a new generation of low-cost, large-scale diagnostic assays for early detection of serious diseases. The company is conceptually based on a systems view of disease where pathophysiology arises from disease-perturbed networks of proteins, genes, and other molecules. Investors include InterWest Partners, The Wellcome Trust, and BioTechCube Luxembourg. Foundational intellectual property is exclusively licensed from the Institute of Systems Biology and Caltech. *
![]() |
Start | 2009-10-14 splitoff |
Group | Biodesix Inc. | |
![]() |
Industry | diagnostics (medical/biological) |
Industry 2 | Xpresys™ test (MRM MS-based protein expression test) | |
![]() |
Person | Hood, Leroy (Lee) (Institute for Systems Biology) |
Person 2 | Luderer, Albert A. (Integrated Diagnostics 201003– CEO before BioTrove CEO before Ligth Sciences Inc before bioMérieux) | |
![]() |
Region | Seattle, WA |
Country | United States (USA) | |
Street | 219 Terry Avenue North Suite 100 | |
City | 98109-5208 Seattle, WA | |
Tel | +1-206-576-6300 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: | ||
Record changed: 2023-07-10 |
Advertisement

More documents for Biodesix Inc.
- [1] Oncimmune Holdings plc. (6/28/19). "Press Release: Oncimmune Secures Strategic Commercialisation Agreement for EarlyCDT Lung in the US with Biodesix, Inc.". London....
- [2] MRM Proteomics Inc.. (1/28/19). "Press Release: MRM Proteomics and Biodesix Partner to Develop Precision Lung Cancer Diagnostics". Montréal, QC & Boulder, CO....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement

» top